1. Home
  2. ALT vs AURA Comparison

ALT vs AURA Comparison

Compare ALT & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • AURA
  • Stock Information
  • Founded
  • ALT 1997
  • AURA 2007
  • Country
  • ALT United States
  • AURA United States
  • Employees
  • ALT N/A
  • AURA N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • AURA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALT Health Care
  • AURA Health Care
  • Exchange
  • ALT Nasdaq
  • AURA Nasdaq
  • Market Cap
  • ALT 457.0M
  • AURA 438.3M
  • IPO Year
  • ALT N/A
  • AURA 2021
  • Fundamental
  • Price
  • ALT $8.25
  • AURA $8.20
  • Analyst Decision
  • ALT Buy
  • AURA Strong Buy
  • Analyst Count
  • ALT 7
  • AURA 4
  • Target Price
  • ALT $20.00
  • AURA $23.00
  • AVG Volume (30 Days)
  • ALT 3.4M
  • AURA 217.1K
  • Earning Date
  • ALT 11-12-2024
  • AURA 11-12-2024
  • Dividend Yield
  • ALT N/A
  • AURA N/A
  • EPS Growth
  • ALT N/A
  • AURA N/A
  • EPS
  • ALT N/A
  • AURA N/A
  • Revenue
  • ALT $52,000.00
  • AURA N/A
  • Revenue This Year
  • ALT N/A
  • AURA N/A
  • Revenue Next Year
  • ALT N/A
  • AURA N/A
  • P/E Ratio
  • ALT N/A
  • AURA N/A
  • Revenue Growth
  • ALT N/A
  • AURA N/A
  • 52 Week Low
  • ALT $5.28
  • AURA $6.63
  • 52 Week High
  • ALT $14.84
  • AURA $12.38
  • Technical
  • Relative Strength Index (RSI)
  • ALT 48.05
  • AURA 39.04
  • Support Level
  • ALT $7.71
  • AURA $8.03
  • Resistance Level
  • ALT $9.59
  • AURA $9.04
  • Average True Range (ATR)
  • ALT 0.81
  • AURA 0.46
  • MACD
  • ALT -0.17
  • AURA -0.01
  • Stochastic Oscillator
  • ALT 17.17
  • AURA 15.20

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: